Literature DB >> 25174058

Long term follow-up of the patients with pelvic organ prolapse after the mesh implantation using strict indication criteria.

P Papcun, M Krizko, B Spodniakova, M Redecha, M Gabor, V Ferianec, I Holly.   

Abstract

OBJECTIVES: Transvaginal polypropylene mesh implantation is one of the techniques used for pelvic organ prolapse (POP) repair. The surgery outcomes depend on the indication criteria used. The aim of our study was to evaluate the outcomes of the mesh implantation using the strict indication criteria. PATIENTS AND METHODS: In 47 women aged 61.7±8.3 years with pelvic organ prolapse (POP-Q≥2) and a history of other surgery in the pelvic region outcomes of the mesh implantation were evaluated for up to 7 years (range 1-7 years).
RESULTS: Forty six of 47 patients (97.8%) had a successful mesh implantation (10 anterior, 22 posterior, 14 combined). Peroperative complications occurred in 3 of 47 patients (6.4%). The anatomic cure (POP-Q≤1) was achieved in 93.5% patients with mesh at 6 months after surgery. Any of the postoperative complications occurred in 16 of 46 women (34.8%). Significantly lower risk of complications was found in the group aged over 65 years compared to the younger patients (p=0.005).
CONCLUSION: This is the first study on the mesh implantation including women only with the history or other surgery in the pelvic region, achieving high anatomic success rate and low risk of complications. Thus, our data support the use of the strict indication criteria for this procedure (Tab. 2, Fig. 2, Ref. 14).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25174058     DOI: 10.4149/bll_2014_059

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  1 in total

1.  A clinical study on the trocar-guided mesh repair system for pelvic organ prolapse surgery.

Authors:  Seul Gi Bak; Jeong Beom Moon; Sang Ki Hong; Kyoung Jin Kim; Kyoung A Kim; Ju Hyang Lee
Journal:  Obstet Gynecol Sci       Date:  2016-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.